Health Tech, or digital health, helps us understand and take control of our own health. But we also cover more traditional health news like medicines, vaccines and medical procedures.
David Baker uses AI's ability to generate hallucination to develop entirely new proteins for medical treatment. His team converts AI's imagined protein structures into real proteins that can be used in healthcare. The method has led to 10 million new proteins.
Childhood cancer mortality in the US has decreased six-fold since the 1950s. Improved treatment methods for leukemia have led to significantly more children surviving the disease. Mortality has decreased significantly for all types of cancer, including lymphoma and multiple myeloma.
Neko Health has secured an investment of $290 million to open more clinics in Europe and the USA. The company has already scanned 10,000 people and has 100,000 people on the waiting list.
A child with a deadly metabolic disease has been successfully treated with a new type of gene editing called ARCUS. The treatment allowed the child to stop their special diet after three months.
New drugs under development against obesity show weight reductions of up to 22 percent of body weight after 48 weeks of treatment. The drug retatrutide, which combines three appetite-regulating hormones, shows the best results so far in clinical trials.
Yale researchers have managed to restore basic cellular functions in a pig brain four hours after death using a specially developed perfusion machine. The technique is now being tested on human brains to develop better treatments for neurological diseases such as Alzheimer's and Parkinson's.
Unlike most other cancers, cervical cancer can be prevented and completely eliminated using existing tools. Several high-income countries are close to elimination, with fewer than four cases per 100,000 women.
Cervical cancer deaths among women under 25 have decreased by 60 percent between 2016-2021 in the USA. A study shows zero cases of cervical cancer among women who were vaccinated against HPV at age 12-13.
The first treatment using CRISPR technology has begun being administered to patients with sickle cell disease and beta-thalassemia. Patients do not produce healthy hemoglobin. Casgevy uses CRISPR to modify the patient's own cells so they produce healthy hemoglobin.